People

Guy Heynen

newtonbiocapital.com

Graduated as MD in 1970 from Liège University (Belgium), Guy is Internal Medicine specialist with experience in immunology and rheumatology. He has extensive experience in clinical development, trial design, and strategic and translational evaluations. Guy joined Pfizer International as International Medical Director in 1982, with assignments in Brussels, New-York, and Zurich, then continued as Regional Medical Monitor in Europe from 2011 to 2014. He was Chief Clinical and Regulatory for Bone Therapeutics up to 2017. Based in Belgium LinkedIn Newton Biocapital publicly documents this person as Chief Medical and Regulatory Officer. The affiliation is scoped to the published role, with no personal cash investment inferred. Historical Neuvasq affiliation: Guy Heynen, MD, graduated from Université de Liège (Belgium) in 1970 with a degree in Medicine. He is an Internal Medicine specialist with expertise in immunology and rheumatology. Guy has extensive expertise in clinical development, trial design, strategic evaluations, and translational evaluations. He started his career with Pfizer International in 1982 as an International Medical Director and served in various assignments in Brussels, New York, and Zurich. Later, from 2011 to 2014, he worked as a Regional Medical Monitor in Europe. Guy then went on to become the Chief Clinical and Regulatory for Bone Therapeutics up until 2017.